These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

195 related articles for article (PubMed ID: 36032659)

  • 21. Long non-coding RNA profile study identifies a metabolism-related signature for colorectal cancer.
    Lu Y; Wang W; Liu Z; Ma J; Zhou X; Fu W
    Mol Med; 2021 Aug; 27(1):83. PubMed ID: 34344319
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Identification of a novel m6A-related lncRNA pair signature for predicting the prognosis of gastric cancer patients.
    Wang JM; Li X; Yang P; Geng WB; Wang XY
    BMC Gastroenterol; 2022 Feb; 22(1):76. PubMed ID: 35189810
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Comprehensive analysis of N6-methylandenosine regulators and m6A-related RNAs as prognosis factors in colorectal cancer.
    Li W; Gao Y; Jin X; Wang H; Lan T; Wei M; Yan W; Wang G; Li Z; Zhao Z; Jiang X
    Mol Ther Nucleic Acids; 2022 Mar; 27():598-610. PubMed ID: 35070494
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Comprehensive analysis of lncRNAs N
    Zuo L; Su H; Zhang Q; Wu WY; Zeng Y; Li XM; Xiong J; Chen LF; Zhou Y
    Aging (Albany NY); 2021 Jan; 13(3):4182-4198. PubMed ID: 33493136
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Development and validation of a novel N6-methyladenosine (m6A)-related multi- long non-coding RNA (lncRNA) prognostic signature in pancreatic adenocarcinoma.
    Yuan Q; Ren J; Li L; Li S; Xiang K; Shang D
    Bioengineered; 2021 Dec; 12(1):2432-2448. PubMed ID: 34233576
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A Novel Pyroptosis-Associated Long Noncoding RNA Signature to Predict the Prognosis of Patients with Colorectal Cancer.
    Chen S; Zhu J; Zhi X
    Int J Gen Med; 2021; 14():6111-6123. PubMed ID: 34611426
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Six-long non-coding RNA signature predicts recurrence-free survival in hepatocellular carcinoma.
    Gu JX; Zhang X; Miao RC; Xiang XH; Fu YN; Zhang JY; Liu C; Qu K
    World J Gastroenterol; 2019 Jan; 25(2):220-232. PubMed ID: 30670911
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Analysis of N6-methyladenosine-related lncRNAs in the tumor immune microenvironment and their prognostic role in pancreatic cancer.
    Liu Y; Wang T; Fang Z; Kong J; Liu J
    J Cancer Res Clin Oncol; 2022 Jul; 148(7):1613-1626. PubMed ID: 35314871
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Identification of Five N6-Methylandenosine-Related ncRNA Signatures to Predict the Overall Survival of Patients with Gastric Cancer.
    Yue Q; Zhang Y; Bai J; Duan X; Wang H
    Dis Markers; 2022; 2022():7765900. PubMed ID: 35774851
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Cross-Talk Between m
    Song W; Ren J; Xiang R; Yuan W; Fu T
    Front Immunol; 2022; 13():740960. PubMed ID: 35350786
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Comprehensive Analysis of N6-Methyladenosine-Related IncRNAs Prognostic Signature and the Associated Immune Infiltrates in Kidney Renal Clear Cell Carcinoma.
    Chen X; Wang L; Tu J; Pan X; Li Y; Yin H; Wang M; Yuan X
    Crit Rev Eukaryot Gene Expr; 2022; 32(1):79-98. PubMed ID: 35377983
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Hypoxia-induced lncRNA STEAP3-AS1 activates Wnt/β-catenin signaling to promote colorectal cancer progression by preventing m
    Zhou L; Jiang J; Huang Z; Jin P; Peng L; Luo M; Zhang Z; Chen Y; Xie N; Gao W; Nice EC; Li JQ; Chen HN; Huang C
    Mol Cancer; 2022 Aug; 21(1):168. PubMed ID: 35986274
    [TBL] [Abstract][Full Text] [Related]  

  • 33. N6-methylandenosine-related lncRNAs play an important role in the prognosis and immune microenvironment of pancreatic ductal adenocarcinoma.
    Hu Y; Chen Y
    Sci Rep; 2021 Sep; 11(1):17844. PubMed ID: 34497315
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Prognostic Value of N6-Methyladenosine-Related lncRNAs in Early-Stage Colorectal Cancer: Association With Immune Cell Infiltration and Chemotherapeutic Drug Sensitivity.
    Xiong Z; Li X; Yin S; Xie M; Mao C; Zhang F; Chen H; Jin L; Lian L
    Front Mol Biosci; 2021; 8():724889. PubMed ID: 34712696
    [No Abstract]   [Full Text] [Related]  

  • 35. N-6 methylation-related lncRNA is potential signature in lung adenocarcinoma and influences tumor microenvironment.
    Zheng J; Zhao Z; Wan J; Guo M; Wang Y; Yang Z; Li Z; Ming L; Qin Z
    J Clin Lab Anal; 2021 Nov; 35(11):e23951. PubMed ID: 34558724
    [TBL] [Abstract][Full Text] [Related]  

  • 36. An eight-long noncoding RNA expression signature for colorectal cancer patients' prognosis.
    Zhang L; Chen S; Wang B; Su Y; Li S; Liu G; Zhang X
    J Cell Biochem; 2019 Apr; 120(4):5636-5643. PubMed ID: 30320902
    [TBL] [Abstract][Full Text] [Related]  

  • 37. LncRNA profile study reveals a seven-lncRNA signature predicts the prognosis of patients with colorectal cancer.
    Huang R; Zhou L; Chi Y; Wu H; Shi L
    Biomark Res; 2020; 8():8. PubMed ID: 32128213
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A long non-coding RNA signature to improve prognosis prediction of colorectal cancer.
    Hu Y; Chen HY; Yu CY; Xu J; Wang JL; Qian J; Zhang X; Fang JY
    Oncotarget; 2014 Apr; 5(8):2230-42. PubMed ID: 24809982
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A Six-LncRNA Expression Signature Associated with Prognosis of Colorectal Cancer Patients.
    Zhao J; Xu J; Shang AQ; Zhang R
    Cell Physiol Biochem; 2018; 50(5):1882-1890. PubMed ID: 30396175
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Relationships of N6-Methyladenosine-Related Long Non-Coding RNAs With Tumor Immune Microenvironment and Clinical Prognosis in Lung Adenocarcinoma.
    Zhao J; Lin X; Zhuang J; He F
    Front Genet; 2021; 12():714697. PubMed ID: 34777460
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.